Ignite Creation Date:
2025-12-24 @ 11:04 PM
Ignite Modification Date:
2026-01-03 @ 2:53 AM
Study NCT ID:
NCT00162669
Status:
UNKNOWN
Last Update Posted:
2006-09-08
First Post:
2005-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab in Advanced Hepatocellular Carcinoma
Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IGR 1123
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |